Cargando…
P-106 COVID-19 PRESENTATION AND OUTCOMES IN 33 PATIENTS WITH AUTOIMMUNE HEPATITIS
BACKGROUND AND AIMS: Clinical course of Covid-19 is not yet established in autoimmune hepatitis (AIH). About 25% of our 400 AIH-outpatients from various states in Brazil are using hydrochloroquine (HCQ) for maintenance or treatment with corticosteroids and immunosuppressants (IS). The aim is to desc...
Autores principales: | Fadini Margon, Julia, Raddatz Reis Vilela, Monique, Damasio Moutinho, Bruna, Rodrigues de Figueiredo, Sabrina, Mitiko Deguti, Marta, Benedita Terrabuio, Débora Raquel, Rachid Cançado, Eduardo Luiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468375/ http://dx.doi.org/10.1016/j.aohep.2021.100466 |
Ejemplares similares
-
The Importance of Autoantibody Detection in Autoimmune Hepatitis
por: Cancado, Eduardo Luiz Rachid, et al.
Publicado: (2015) -
HLA-related genetic susceptibility in autoimmune hepatitis according to autoantibody profile
por: Cancado, Eduardo Luiz Rachid, et al.
Publicado: (2022) -
Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission
por: Paranaguá‐Vezozzo, Denise Cerqueira, et al.
Publicado: (2023) -
Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2017) -
Chloroquine Is Effective for Maintenance of Remission in Autoimmune Hepatitis: Controlled, Double‐Blind, Randomized Trial
por: Raquel Benedita Terrabuio, Débora, et al.
Publicado: (2018)